Denna sida på svenska
Loading profile information...

Publications

Assessing longitudinal trends in cardiac function among pediatric patients with chronic kidney disease
Tranæus Lindblad Y, Vavilis G, Axelsson J, Herthelius M, Bárány P
Pediatric nephrology (Berlin, Germany) 2016;31(9):1485-97

Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly
Sjöberg B, Qureshi Ar, Heimbürger O, Stenvinkel P, Lind L, Larsson A, et al
Journal of internal medicine 2016;279(2):173-9

Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD
Sun J, Axelsson J, Machowska A, Heimbürger O, Bárány P, Lindholm B, et al
Clinical journal of the American Society of Nephrology : CJASN 2016;11(7):1163-72

Dialysis modality and nutritional status are associated with variability of inflammatory markers
Snaedal S, Qureshi Ar, Lund Sh, Germanis G, Hylander B, Heimbürger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;31(8):1320-7

ELEVATED CIRCULATING S100A12 ASSOCIATES WITH VASCULAR DISEASE AND WORSE CLINICAL OUTCOME IN PERITONEAL DIALYSIS PATIENTS
Isoyama N, Machowska A, Qureshi Ar, Yamamoto T, Anderstam B, Heimburger O, et al
PERITONEAL DIALYSIS INTERNATIONAL 2016;36(3):269-76

Peritoneal dialysis impairs nitric oxide homeostasis and may predispose infants with low systolic blood pressure to cerebral ischemia
Carlström M, Cananau C, Checa A, Wide K, Sartz L, Svensson A, et al
Nitric oxide : biology and chemistry 2016;58():1-9

Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease
Machowska A, Sun J, Qureshi Ar, Isoyama N, Leurs P, Anderstam B, et al
PloS one 2016;11(10):e0163826-

Prevalence and recognition of chronic kidney disease in Stockholm healthcare
Gasparini A, Evans M, Coresh J, Grams Me, Norin O, Qureshi Ar, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2016;():-

Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney Disease
Missailidis C, Hällqvist J, Qureshi Ar, Barany P, Heimbürger O, Lindholm B, et al
PloS one 2016;11(1):e0141738-

The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness
Runesson B, Gasparini A, Qureshi Ar, Norin O, Evans M, Barany P, et al
Clinical kidney journal 2016;9(1):119-27

Vertebral bone density associates with coronary artery calcification and is an independent predictor of poor outcome in end-stage renal disease patients
Chen Z, Qureshi Ar, Ripsweden J, Wennberg L, Heimburger O, Lindholm B, et al
Bone 2016;92():50-57

Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease
Meuwese Cl, Olauson H, Qureshi Ar, Ripsweden J, Barany P, Vermeer C, et al
PloS one 2015;10(7):e0132353-

Clinical determinants of reduced physical activity in hemodialysis and peritoneal dialysis patients
Cobo G, Gallar P, Gama-axelsson T, Di Gioia C, Qureshi Ar, Camacho R, et al
JOURNAL OF NEPHROLOGY 2015;28(4):503-10

Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis
Carlsson Ac, Carrero Jj, Stenvinkel P, Bottai M, Barany P, Larsson A, et al
Blood purification 2015;39(4):259-65

High Levels of Soluble Tumor Necrosis Factor Receptors 1 and 2 and Their Association with Mortality in Patients Undergoing Hemodialysis
Carlsson Ac, Carrero Jj, Stenvinkel P, Bottai M, Barany P, Larsson A, et al
CARDIORENAL MEDICINE 2015;5(2):89-95

Increased circulating sclerostin levels in end-stage renal disease predict biopsy-verified vascular medial calcification and coronary artery calcification
Qureshi Ar, Olauson H, Witasp A, Haarhaus M, Brandenburg V, Wernerson A, et al
KIDNEY INTERNATIONAL 2015;88(6):1356-1364

INCREASED LEVELS OF MODIFIED ADVANCED OXIDATION PROTEIN PRODUCTS ARE ASSOCIATED WITH CENTRAL AND PERIPHERAL BLOOD PRESSURE IN PERITONEAL DIALYSIS PATIENTS
Xu H, Cabezas-rodriguez I, Qureshi Ar, Heimburger O, Barany P, Snaedal S, et al
PERITONEAL DIALYSIS INTERNATIONAL 2015;35(4):460-70

OXIDATIVE DNA DAMAGE AND MORTALITY IN HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
Xu H, Watanabe M, Qureshi Ar, Heimburger O, Barany P, Anderstam B, et al
PERITONEAL DIALYSIS INTERNATIONAL 2015;35(2):206-15

Plasma nitrate/nitrite removal by peritoneal dialysis might predispose infants with low blood pressure to cerebral ischaemia
Carlström M, Wide K, Lundvall M, Cananau C, Svensson A, Lundberg Jo, et al
Clinical kidney journal 2015;8(2):215-8

Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients
Isoyama N, Leurs P, Qureshi Ar, Bruchfeld A, Anderstam B, Heimburger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015;30(1):84-91

Serum hepatocyte growth factor is associated with truncal fat mass and increased mortality in chronic kidney disease stage 5 patients with protein-energy wasting
Yuan J, Watanabe M, Suliman M, Qureshi Ar, Axelsson J, Bárány P, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2015;30(2):274-82

Validation of a competitive ELISA assay for the quantification of human serum hepcidin
Dahlfors G, Stål P, Hansson Ec, Bàràny P, Sisowath C, Onelöv L, et al
Scandinavian journal of clinical and laboratory investigation 2015;75(8):652-8

Comparative associations of muscle mass and muscle strength with mortality in dialysis patients
Isoyama N, Qureshi Ar, Avesani Cm, Lindholm B, Bàràny P, Heimbürger O, et al
Clinical journal of the American Society of Nephrology : CJASN 2014;9(10):1720-8

Delta-He: a novel marker of inflammation predicting mortality and ESA response in peritoneal dialysis patients
Danielson K, Beshara S, Qureshi Ar, Heimbürger O, Lindholm B, Hansson M, et al
Clinical kidney journal 2014;7(3):275-81

Determinants of N-terminal pro-brain natriuretic peptide variation in hemodialysis patients and prediction of survival
Snaedal S, Qureshi Ar, Carrero Jj, Heimbürger O, Stenvinkel P, Bárány P
Blood purification 2014;37(2):138-45

IGF-1 and survival in ESRD
Jia T, Gama Axelsson T, Heimbürger O, Bárány P, Lindholm B, Stenvinkel P, et al
Clinical journal of the American Society of Nephrology : CJASN 2014;9(1):120-7

Selection of genetic and phenotypic features associated with inflammatory status of patients on dialysis using relaxed linear separability method
Bobrowski L, Łukaszuk T, Lindholm B, Stenvinkel P, Heimburger O, Axelsson J, et al
PloS one 2014;9(1):e86630-

Subclinical Atherosclerosis, Endothelial Function, and Serum Inflammatory Markers in Chronic Kidney Disease Stages 3 to 4
Ghanavatian S, Diep Lm, Barany P, Heimburger O, Seeberger A, Stenvinkel P, et al
ANGIOLOGY 2014;65(5):443-9

The use of estimated glomerular filtration rate for dose adjustment of medications in the elderly
Elinder Cg, Bárány P, Heimbürger O
Drugs & aging 2014;31(7):493-9

Three-month variation of plasma pentraxin 3 compared with C-reactive protein, albumin and homocysteine levels in haemodialysis patients
Sjöberg B, Snaedal S, Stenvinkel P, Qureshi Ar, Heimbürger O, Bárány P
Clinical kidney journal 2014;7(4):373-9

Circulating vascular endothelial growth factor (VEGF) and its soluble receptor 1 (sVEGFR-1) are associated with inflammation and mortality in incident dialysis patients
Yuan J, Guo Q, Qureshi Ar, Anderstam B, Eriksson M, Heimbürger O, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28(9):2356-63

Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients
Huang X, Stenvinkel P, Qureshi Ar, Cederholm T, Bárány P, Heimbürger O, et al
Journal of internal medicine 2013;273(3):263-72

Determinants and survival implications of low bone mineral density in end-stage renal disease patients
Park Sh, Jia T, Qureshi Ar, Bárány P, Heimbürger O, Larsson Te, et al
Journal of nephrology 2013;26(3):485-94

Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients
Jia T, Qureshi Ar, Brandenburg V, Ketteler M, Barany P, Heimburger O, et al
American journal of nephrology 2013;37(5):462-71

[Drug dosage should be based on renal function]
Elinder Cg, Bárány P, Heimbürger O
Lakartidningen 2013;110(47):2119-20

Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality
Frostegård Ag, Hua X, Su J, Carrero Jj, Heimbürger O, Bárány P, et al
Clinical and experimental immunology 2013;174(3):441-8

Kidney Disease Improving Global Outcomes (Kdigo) Guidelines on Anaemia Management in Chronic Kidney Disease: A European Renal Best Practice (Erbp) Position Statement
Era-edta Erbp Advisory Board, Locatelli F, Barany P, Covic A, De Francisco A, Del Vecchio L, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2013;28(6):1346-59

Left ventricular diastolic dysfunction by tissue Doppler echocardiography in pediatric chronic kidney disease
Lindblad Yt, Axelsson J, Balzano R, Vavilis G, Chromek M, Celsi G, et al
Pediatric nephrology (Berlin, Germany) 2013;28(10):2003-13

Nonthyroidal illness: a risk factor for coronary calcification and arterial stiffness in patients undergoing peritoneal dialysis?
Meuwese Cl, Carrero Jj, Cabezas-rodríguez I, Heimburger O, Barany P, Lindholm B, et al
Journal of internal medicine 2013;274(6):584-93

Self-rated appetite as a predictor of mortality in patients with stage 5 chronic kidney disease
Gama-axelsson T, Lindholm B, Bárány P, Heimbürger O, Stenvinkel P, Qureshi Ar
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2013;23(2):106-13

Subclinical versus overt obesity in dialysis patients: more than meets the eye
Gracia-iguacel C, Qureshi Ar, Avesani Cm, Heimbürger O, Huang X, Lindholm B, et al
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2013;28 Suppl 4():iv175-81

Baseline Levels and Trimestral Variation of Triiodothyronine and Thyroxine and Their Association with Mortality in Maintenance Hemodialysis Patients
Meuwese Cl, Dekker Fw, Lindholm B, Qureshi Ar, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2012;7(1):131-8

Essential polyunsaturated fatty acids, inflammation and mortality in dialysis patients
Huang Xy, Stenvinkel P, Qureshi Ar, Riserus U, Cederholm T, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2012;27(9):3615-20

Hypogonadism in Males with Chronic Kidney Disease: Another Cause of Resistance to Erythropoiesis-Stimulating Agents?
Stenvinkel P, Barany P
PERITONEAL DIALYSIS - STATE-OF-THE-ART 2012 2012;:35-9

Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease
Breit Sn, Carrero Jj, Tsai Vww, Yagoutifam N, Luo W, Kuffner T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2012;27(1):70-5

Pentraxin 3, a sensitive early marker of hemodialysis-induced inflammation
Sjöberg B, Qureshi Ar, Anderstam B, Alvestrand A, Bárány P
Blood purification 2012;34(3-4):290-7

Plasma Fatty Acids in Chronic Kidney Disease: Nervonic Acid Predicts Mortality
Shearer Gc, Carrero Jj, Heimburger O, Barany P, Stenvinkel P
JOURNAL OF RENAL NUTRITION 2012;22(2):277-83

Serum Albumin as Predictor of Nutritional Status in Patients with ESRD
Gama-axelsson T, Heimburger O, Stenvinkel P, Barany P, Lindholm B, Qureshi Ar
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2012;7(9):1446-53

Testosterone deficiency is a cause of anaemia and reduced responsiveness to erythropoiesis-stimulating agents in men with chronic kidney disease
Carrero Jj, Barany P, Yilmaz Mi, Qureshi Ar, Sonmez A, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2012;27(2):709-15

The enigma of decreased creatinine generation in acute kidney injury
Heimburger O, Stenvinkel P, Barany P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2012;27(11):3973-4

Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange
Krmar Rt, Holtbäck U, Linné T, Berg Ub, Celsi G, Söderberg Mp, et al
Clinical nephrology 2011;75 Suppl 1():4-10

Acute renal failure in dense deposit disease: complete recovery after combination therapy with immunosuppressant and plasma exchange
Krmar Rt, Holtback U, Linne T, Berg Ub, Celsi G, Soderberg Mp, et al
CLINICAL NEPHROLOGY 2011;:S4-S10

Circulating Follistatin in Patients with Chronic Kidney Disease: Implications for Muscle Strength, Bone Mineral Density, Inflammation, and Survival
Miyamoto T, Carrero Jj, Qureshi Ar, Anderstarn B, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(5):1001-8

Influence of Erythropoiesis-Stimulating Agents on Glycated Hemoglobin in Nondiabetic Kidney Diseases at the Start of Dialysis
Cordeiro Ac, Carrero Jj, Barany P, Qureshi Ar, Heimburger O, Lindholm B, et al
AMERICAN JOURNAL OF NEPHROLOGY 2011;33(1):17-24

Inverse Relationship between the Inflammatory Marker Pentraxin-3, Fat Body Mass, and Abdominal Obesity in End-Stage Renal Disease
Miyamoto T, Qureshi Ar, Heimburger O, Barany P, Carrero K, Sjoberg B, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2011;6(12):2785-91

Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease
Wikstrom B, Bhandari S, Barany P, Kalra Pa, Ladefoged S, Wilske J, et al
JOURNAL OF NEPHROLOGY 2011;24(5):589-96

New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria
Smerud Hk, Barany P, Lindstrom K, Fernstrom A, Sandell A, Pahlsson P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(10):3237-42

Prevalence and clinical implications of testosterone deficiency in men with end-stage renal disease
Carrero Jj, Qureshi Ar, Nakashima A, Arver S, Parini P, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(1):184-90

Protein-energy wasting modifies the association of ghrelin with inflammation, leptin, and mortality in hemodialysis patients
Carrero Jj, Nakashima A, Qureshi Ar, Lindholm B, Heimburger O, Barany P, et al
KIDNEY INTERNATIONAL 2011;79(7):749-56

Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-alpha are similarly associated with survival in haemodialysis patients
Meuwese Cl, Snaedal S, Halbesma N, Stenvinkel P, Dekker Fw, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2011;26(4):1313-8

Abdominal fat deposition is associated with increased inflammation, protein-energy wasting and worse outcome in patients undergoing haemodialysis
Cordeiro Ac, Qureshi Ar, Stenvinkel P, Heimburger O, Axelsson J, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(2):562-8

Clinical importance of an elevated circulating chemerin level in incident dialysis patients
Yamamoto T, Qureshi Ar, Anderstam B, Heimburger O, Barany P, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(12):4017-23

Effect of Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and the Proinflammatory RAGE Ligand (EN-RAGE, S100A12) on Mortality in Hemodialysis Patients
Nakashima A, Carrero Jj, Qureshi Ar, Miyamoto T, Anderstam B, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2010;5(12):2213-9

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
Olauson H, Qureshi Ar, Miyamoto T, Barany P, Heimburger O, Lindholm B, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(9):3033-8

Variations in C-reactive protein during a single haemodialysis session do not associate with mortality
Meuwese Cl, Halbesma N, Stenvinkel P, Dekker Fw, Molanaei H, Qureshi Ar, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(11):3717-23

Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels
Carrero Jj, Witasp A, Stenvinkel P, Qureshi Ar, Heimburger O, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2010;25(3):901-6

Additive Effects of Soluble TWEAK and Inflammation on Mortality in Hemodialysis Patients
Carrero Jj, Ortiz A, Qureshi Ar, Martin-ventura Jl, Barany P, Heimburger O, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2009;4(1):110-8

Associations of VEGF and its receptors sVEGFR-1 and-2 with cardiovascular disease and survival in prevalent haemodialysis patients
Guo Qy, Carrero Jj, Yu Xq, Barany P, Qureshi Ar, Eriksson M, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2009;24(11):3468-73

[Choose the right method fo estimation of kidney function. The nature of the problem determines which method should be used]
Heimbürger O, Bárány P
Lakartidningen 2009;106(7):420-1

Comorbidity and Acute Clinical Events as Determinants of C-Reactive Protein Variation in Hemodialysis Patients: Implications for Patient Survival
Snaedal S, Heimburger O, Qureshi Ar, Danielsson A, Wikstrom B, Fellstrom B, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2009;53(6):1024-33

Elevated Serum Macrophage Migration Inhibitory Factor (MIF) Concentrations in Chronic Kidney Disease (CKD) Are Associated with Markers of Oxidative Stress and Endothelial Activation
Bruchfeld A, Carrero Jj, Qureshi Ar, Lindholm B, Barany P, Heimburger O, et al
MOLECULAR MEDICINE 2009;15(3-4):70-5

Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease
Matsubara K, Stenvinkel P, Qureshi Ar, Carrero Jj, Axelsson J, Heimburger O, et al
JOURNAL OF NEPHROLOGY 2009;22(6):774-82

Intercurrent events and comorbid conditions influence hemoglobin level variability in dialysis patients
Defrancisco Alm, Macdougall Ic, Carrera F, Braun J, Barany P, Bridges I, et al
CLINICAL NEPHROLOGY 2009;71(4):397-404

Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis
Carrero Jj, Hua X, Stenvinkel P, Qureshi Ar, Heimburger O, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2009;24(11):3454-60

Low Serum Testosterone Increases Mortality Risk among Male Dialysis Patients
Carrero Jj, Qureshi Ar, Parini P, Arver S, Lindholm B, Barany P, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2009;20(3):613-20

N-Terminal Pro-Brain Natriuretic Peptide Independently Predicts Protein Energy Wasting and Is Associated with All-Cause Mortality in Prevalent HD Patients
Guo Q, Barany P, Qureshi Ar, Snaedal S, Heimburger O, Stenvinkel P, et al
AMERICAN JOURNAL OF NEPHROLOGY 2009;29(6):516-23

Serum Retinol-Binding Protein Concentration and Its Association with Components of the Uremic Metabolic Syndrome in Nondiabetic Patients with Chronic Kidney Disease Stage 5
Axelsson J, O'byrne Sm, Blaner Ws, Carrero Jj, Bruchfeld A, Heimburger O, et al
AMERICAN JOURNAL OF NEPHROLOGY 2009;29(5):447-53

Soluble CD14 Levels, Interleukin 6, and Mortality Among Prevalent Hemodialysis Patients
Raj Dsc, Carrero Jj, Shah Vo, Qureshi Ar, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2009;54(6):1072-80

Temporal discrepancies in the association between the apoB/apoA-I ratio and mortality in incident dialysis patients
Chmielewski M, Carrero Jj, Qureshi Ar, Axelsson J, Heimburger O, Berglund L, et al
JOURNAL OF INTERNAL MEDICINE 2009;265(6):708-16

Variations in graft and patient survival after kidney transplantation in Sweden: caveats in interpretation of center effects when benchmarking
Elinder Cg, Ekberg H, Barany P, Fehrman-ekholm I, Jensen G, Norden G, et al
TRANSPLANT INTERNATIONAL 2009;22(11):1051-7

Bone mineral density in end-stage renal disease patients: Association with wasting, cardiovascular disease and mortality
Matsubara K, Suliman Me, Qureshi Ar, Axelsson J, Martola L, Heimburger O, et al
BLOOD PURIFICATION 2008;26(3):284-90

Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality
Watanabe M, Suliman Me, Qureshi Ar, Garcia-lopez E, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2008;87(6):1860-6

Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
Valli A, Carrero Jj, Qureshi Ar, Garibotto G, Barany P, Axelsson J, et al
CLINICA CHIMICA ACTA 2008;395(1-2):106-10

High mobility group box protein-1 correlates with renal function in chronic kidney disease (CKD)
Bruchfeld A, Qureshi Ar, Lindholm B, Barany P, Yang Lh, Stenvinkel P, et al
MOLECULAR MEDICINE 2008;14(3-4):109-15

Hyperinsulinemia and Insulin Resistance, Early Cardiovascular Risk Factors in Children with Chronic Kidney Disease
Lindblad Yt, Axelsson J, Barany P, Celsi G, Lindholm B, Qureshi Ar, et al
BLOOD PURIFICATION 2008;26(6):518-25

Is fetuin-A/alpha 2-Heremans-Schmid glycoprotein associated with the metabolic syndrome in patients with chronic kidney disease?
Axelsson J, Wang X, Ketteler M, Qureshi Ar, Heimburger O, Barany P, et al
AMERICAN JOURNAL OF NEPHROLOGY 2008;28(4):669-76

Lipoprotein Lipase 1595 C/G and Hepatic Lipase-480 C/T Polymorphisms - Impact on Lipid Profile in Incident Dialysis Patients
Chmielewski M, Stenvinkel P, Luttropp K, Suliman Me, Qureshi Ar, Carrero Jj, et al
BLOOD PURIFICATION 2008;26(6):555-60

Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients
Metry G, Stenvinkel P, Qureshi Ar, Carrero Jj, Yilmaz Mi, Barany P, et al
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 2008;38(11):804-11

Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients
Carrero Jj, Chmielewski M, Axelsson J, Snaedal S, Heimburger O, Barany P, et al
CLINICAL NUTRITION 2008;27(4):557-64

Novel links between the long pentraxin 3, endothelial dysfunction, and albuminuria in early and advanced chronic kidney disease
Suliman Me, Yimaz Mi, Carrero Jj, Qureshi Ar, Saglam M, Ipcioglu Om, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2008;3(4):976-85

Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients
Carrero Jj, Stenvinkel P, Fellstrom B, Qureshi Ar, Lamb K, Heimburger O, et al
JOURNAL OF INTERNAL MEDICINE 2008;263(3):302-12

The long pentraxin PTX-3 in prevalent hemodialysis patients: associations with comorbidities and mortality
Suliman Me, Qureshi Ar, Carrero Jj, Barany P, Yilmaz Mi, Snaedal-jonsdottir S, et al
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE 2008;101(5):397-405

Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients
Kato S, Lindholm B, Axelsson J, Qureshi Ra, Barany P, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(9):2571-7

Associations between the CYBA 242C/T and the MPO-463G/A polymorphisms, oxidative stress and cardiovascular disease in chronic kidney disease patients
Grahl Da, Axelsson J, Nordfors L, Heimburger O, Barany P, Qureshi Ar, et al
BLOOD PURIFICATION 2007;25(2):210-8

Changes in fat mass after initiation of maintenance dialysis is influenced by the uncoupling protein 2 exon 8 insertion/deletion polymorphism
Wang X, Axelsson J, Nordfors L, Qureshi Ar, Avesani C, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(1):196-202

Circulating levels of Visfatin/Pre-B-Cell colony-enhancing factor 1 in relation to genotype,GFR, body composition, and survival in patients with CKD
Axelsson J, Witasp A, Carrero Jj, Qureshi Ar, Suliman Me, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2007;49(2):237-44

Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
Carrero Jj, Qureshi Ar, Axelsson J, Yilmaz Mi, Rehnmark S, Witt Mr, et al
JOURNAL OF INTERNAL MEDICINE 2007;262(6):690-701

Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetites
Carrero Jj, Qureshi Ar, Axelsson J, Avesani Cm, Suliman Me, Kato S, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2007;85(3):695-701

Homocysteine-lowering is not a primary target for cardiovascular disease prevention in chronic kidney disease patients
Suliman Me, Lindholm B, Barany P, Qureshi Ar, Stenvinkel P
SEMINARS IN DIALYSIS 2007;20(6):523-9

Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
Stenvinkel P, Karimi M, Johansson S, Axelsson J, Suliman M, Lindholm B, et al
JOURNAL OF INTERNAL MEDICINE 2007;261(5):488-99

Influence of cytokine gene polymorphisms on erythropoetin dose requirements in chronic haemodialysis patients
Girndt M, Stenvinkel P, Ulrich C, Axelsson J, Nordfors L, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(12):3586-92

Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease
Bárány P, Müller Hj
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2007;22 Suppl 4():iv10-iv18

Maintaining control over haemoglobin levels: optimizing the management of anaemia in chronic kidney disease
Barany P, Muller Hj
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;:10-18

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality
Honda H, Qureshi Ar, Axelsson J, Heimburger O, Suliman Me, Barany P, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2007;86(3):633-8

Oral health and pro-inflammatory status in end-stage renal disease patients
Buhlin K, Bárány P, Heimbürger O, Stenvinkel P, Gustafsson A
Oral health & preventive dentistry 2007;5(3):235-44

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors
Valli A, Suliman Me, Meert N, Vanholder R, Lindholm B, Stenvinkel P, et al
CLINICA CHIMICA ACTA 2007;379(1-2):87-94

Plasma pentraxin 3 in patients with chronic kidney disease: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality
Tong M, Carrero Jj, Qureshi Ar, Anderstam B, Heimburger O, Barany P, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2007;2(5):889-97

The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation
Suliman M, Stenvinkel P, Qureshi Ar, Kalantar-zadeh K, Barany P, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2007;22(1):209-17

Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?
Axelsson J, Qureshi Ar, Divino Jc, Barany P, Heimburger O, Lindholm B, et al
EUROPEAN JOURNAL OF CLINICAL NUTRITION 2006;60(6):718-26

Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD
Axelsson J, Moller Hj, Witasp A, Qureshi Ar, Carrero Jj, Heimburger O, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;48(6):916-25

Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance
Axelsson J, Bergsten A, Qureshi Ar, Heimburger O, Barany P, Lonnqvist Fl, et al
KIDNEY INTERNATIONAL 2006;69(3):596-604

Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients
Suliman Me, Stenvinkel P, Barany P, Qureshi Ar, Lindholm B
SEMINARS IN NEPHROLOGY 2006;26(1):14-9

J-shaped mortality relationship for uric acid in CKD
Suliman Me, Johnson Rj, Garcia-lopez E, Qureshi Ar, Molinaei H, Carrero Jj, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;48(5):761-71

Left ventricular function in patients with chronic kidney disease evaluated by colour tissue Doppler velocity imaging
Hayashi Sy, Rohani M, Lindholm B, Brodin La, Lind B, Barany P, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;21(1):125-32

Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy
Suliman Me, Stenvinkel P, Jogestrand T, Maruyama Y, Qureshi Ar, Barany P, et al
CLINICAL NEPHROLOGY 2006;66(6):418-25

Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD
Honda H, Qureshi Ar, Heimburger O, Barany P, Wang K, Pecoits-filho R, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2006;47(1):139-48

Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients
Stenvinkel P, Rodriguez-ayala E, Massy Za, Qureshi Ar, Barany P, Fellstrom B, et al
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2006;1(2):281-7

Body fat mass and serum leptin levels influence epoetin sensitivity in patients with ESRD
Axelsson J, Qureshi Ar, Heimburger O, Lindholm B, Stenvinkel P, Barany P
AMERICAN JOURNAL OF KIDNEY DISEASES 2005;46(4):628-34

Inflammation and resistance to erythropoiesis-stimulating agents - what do we know and what needs to be clarified?
Smrzova J, Balla J, Barany P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2005;:2-7

Inflammation contributes to low plasma amino acid concentrations in patients with chronic kidney disease
Suliman Me, Qureshi Ar, Stenvinkel P, Pecoits R, Barany P, Heimburger O, et al
AMERICAN JOURNAL OF CLINICAL NUTRITION 2005;82(2):342-9

Interleukin-1 gene cluster polymorphisms are associated with nutritional status and inflammation in patients with end-stage renal disease
Maruyama Y, Nordfors L, Stenvinkel P, Heimburger O, Barany P, Pecoits R, et al
BLOOD PURIFICATION 2005;23(5):384-93

[Iron deficiency in renal anemia is difficult to diagnose. Evidence-based guidelines improve diagnosis and treatment]
Bárány P
Lakartidningen 2005;102(37):2536-7

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin
Stenvinkel P, Wang K, Qureshi Ar, Axelsson J, Pecoits R, Gao P, et al
KIDNEY INTERNATIONAL 2005;67(6):2383-92

Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy
Yao Q, Nordfors L, Axelsson J, Heimburger O, Qureshi Ar, Barany P, et al
ATHEROSCLEROSIS 2005;182(1):105-11

[Selection of dialysis type--a crucial decision. Peritoneal dialysis is better for the patient and cheaper for the society]
Jonsdottir Ss, Stenvinkel P, Bárány P
Lakartidningen 2005;102(5):281-2

Adiponectin in renal disease: Relationship to phenotype and genetic variation in the gene encoding adiponectin
Stenvinkel P, Marchlewska A, Pecoits R, Heimburger O, Zhang Zz, Hoff C, et al
KIDNEY INTERNATIONAL 2004;65(1):274-81

Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy
Suliman Me, Stenvinkel P, Qureshi Ar, Barany P, Heimburger O, Anderstam B, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2004;44(3):455-65

Malnutrition and inflammation are associated with impaired pulmonary function in patients with chronic kidney disease
Nascimento Mm, Qureshi Ar, Stenvinkel P, Pecoits-filho R, Heimburger O, Cederholm T, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;19(7):1823-8

Revised European Best Practice Guidelines for the Management of Anaemia in Patients with Chronic Renal Failure
Locatelli F, Aljama Pa, Barany P, Canaud B, Carrera F, Eckardt Ku, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2004;:1-47

Varying intervals of subcutaneous epoetin alfa in hemodialysis patients
Beshara S, Barany P, Gutierrez A, Wikstrom B
JOURNAL OF NEPHROLOGY 2004;17(4):525-30

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients
Pecoits R, Stenvinkel P, Marchlewska A, Heimburger O, Barany P, Hoff Cm, et al
KIDNEY INTERNATIONAL 2003;:S172-6

Associations between circulating inflammatory markers and residual renal function in CRF patients
Pecoits R, Heimburger O, Barany P, Suliman M, Fehrman-ekholm I, Lindholm B, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2003;41(6):1212-8

Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: Influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus
Suliman Me, Stenvinkel P, Baranyi P, Heimburger O, Anderstam B, Lindholm B
AMERICAN JOURNAL OF KIDNEY DISEASES 2003;41(3):S89-95

Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy
Suliman Me, Heimburger O, Barany P, Anderstam B, Pecoits R, Ayala Er, et al
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 2003;14(6):1614-22

A comparative analysis of nutritional parameters as predictors of outcome in male and female ESRD patients
Stenvinkel P, Barany P, Chung Sh, Lindholm B, Heimburger O
NEPHROLOGY DIALYSIS TRANSPLANTATION 2002;17(7):1266-74

Anaemia, rHuEPO resistance, and cardiovascular disease in end-stage renal failure: links to inflammation and oxidative stress
Stenvinkel P, Barany P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2002;:32-7

Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease
Suliman Me, Barany P, Divino Jc, Qureshi Ar, Stenvinkel P, Heimburger O, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2002;17(6):1050-6

Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment
Pecoits-filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2002;17(9):1684-8

Mortality, malnutrition, and atherosclerosis in ESRD: what is the role of interleukin-6?
Stenvinkel P, Barany P, Heimbürger O, Pecoits-filho R, Lindholm B
Kidney international. Supplement 2002;(80):103-8

Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?
Stenvinkel P, Barany P, Heimburger O, Pecoits R, Lindholm B
KIDNEY INTERNATIONAL 2002;:S103-S108

Plasma sulfur amino acids in relation to cardiovascular disease, nutritional status, and diabetes mellitus in patients with chronic renal failure at start of dialysis therapy
Suliman Me, Stenvinkel P, Heimburger O, Barany P, Lindholm B, Bergstrom J
AMERICAN JOURNAL OF KIDNEY DISEASES 2002;40(3):480-8

Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients
European-austr Nesp 970200 Study Grp, Vanrenterghem Y, Barany P, Mann Jfe, Kerr Pg, Wilson J, et al
KIDNEY INTERNATIONAL 2002;62(6):2167-75

Recurrence of hemolytic uremic syndrome after live related renal transplantation associated with subsequent de novo disease in the donor
Donne Rl, Abbs I, Barany P, Elinder Cg, Little M, Conlon P, et al
AMERICAN JOURNAL OF KIDNEY DISEASES 2002;40(6):E22-

Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers
Barany P, Stenvinkel B, Ottosson-seeberger A, Alvestrand A, Morrow J, Roberts Jj, et al
NEPHROLOGY DIALYSIS TRANSPLANTATION 2001;16(3):580-4

Effects of methionine loading on plasma and erythrocyte sulphur amino acids and sulph-hydryls before and after co-factor supplementation in haemodialysis patients
Suliman Me, Divino Jc, Barany P, Anderstam B, Lindholm B, Bergstrom J
NEPHROLOGY DIALYSIS TRANSPLANTATION 2001;16(1):102-10

Hyperhomocysteinemia in chronic renal failure patients: Relation to nutritional status and cardiovascular disease
Suliman Me, Lindholm B, Barany P, Bergstrom J
CLINICAL CHEMISTRY AND LABORATORY MEDICINE 2001;39(8):734-8

Inflammation, serum C-reactive protein, and erythropoietin resistance
Barany P
NEPHROLOGY DIALYSIS TRANSPLANTATION 2001;16(2):224-7

Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients
Suliman Me, Qureshi Ar, Barany P, Stenvinkel P, Divino Jc, Anderstam B, et al
KIDNEY INTERNATIONAL 2000;57(4):1727-35

An educational programme for persistent life-style changes in patients with chronic renal disease
Bergström K, Bárány P, Holm I
EDTNA/ERCA journal (English ed.) 1999;25(4):42-4

Effects of high-dose folic acid and pyridoxine on plasma and erythrocyte sulfur amino acids in hemodialysis patients
Suliman Me, Divino Jc, Barany P, Anderstam B, Lindholm B, Bergstrom J
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY 1999;10(6):1287-96

Free amino-acid levels simultaneously collected in plasma, muscle, and erythrocytes of uraemic patients
Divino Jc, Barany P, Stehle P, Furst P, Bergstrom J
NEPHROLOGY DIALYSIS TRANSPLANTATION 1997;12(11):2339-48

High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
Barany P, Divino Jc, Bergstrom J
AMERICAN JOURNAL OF KIDNEY DISEASES 1997;29(4):565-8

Management of iron deficiency in renal anemia: Guidelines for the optimal therapeutic approach in erythropoietin-treated patients
Drueke Tb, Barany P, Cazzola M, Eschbach Jw, Grutzmacher P, Kaltwasser Jp, et al
CLINICAL NEPHROLOGY 1997;48(1):1-8

Serum ferritin and tissue iron in anemic dialysis patients
Barany P, Eriksson Lc, Hultcrantz R, Pettersson E, Bergstrom J
MINERAL AND ELECTROLYTE METABOLISM 1997;23(3-6):273-6

Endocrinology and PD: optimal treatment of anemia in peritoneal dialysis patients
Bárány P
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1996;16 Suppl 1():S260-6

SUBCUTANEOUS EPOETIN-BETA IN RENAL ANEMIA - AN OPEN MULTICENTER DOSE TITRATION STUDY OF PATIENTS ON CONTINUOUS PERITONEAL-DIALYSIS
Barany P, Clyne N, Hylander B, Johansson Ac, Simonsen O, Larsson R, et al
PERITONEAL DIALYSIS INTERNATIONAL 1995;15(1):54-60

Show all publications